![]() |
市场调查报告书
商品编码
1623074
抗菌医疗用纺织品市场:各地区,2024年~2031年Antimicrobial Medical Textiles Market By Fabric (Cotton, Polyester, Polyamide), Application (Implantable, Non-Implantable), End-User (Hospitals and Clinics, Home Healthcare), & Region for 2024-2031 |
||||||
2024-2031年抗菌医用纺织品市场评估
不断增加的医疗负担和对感染预防和控制的日益重视正在推动对抗菌医用纺织品的需求。不断上涨的医疗保健成本增加了对有效且具有成本效益的解决方案的需求,以减少医疗保健相关感染 (HAI)。抗菌纺织品是防止危险感染传播、改善病患治疗效果、降低医疗成本的可行策略。 2024年市场规模将超过155.1亿美元,2031年将达到约260.7亿美元。
抗生素抗药性日益频繁,对公共卫生构成重大威胁。抗菌纺织品可以提供一种无需抗生素的感染控制替代方法,从而帮助解决抗生素抗药性问题。透过在医用纺织品中添加抗菌特性,医疗机构可以提供更卫生的氛围,减少对抗生素的依赖,并减少抗生素抗药性疾病的发生率。对具有成本效益和高效的抗菌医用纺织品的需求不断增长,将推动市场从2024年到2031年以7.40%的复合年增长率增长。
抗菌医用纺织品市场定义/概述
抗菌医用纺织品是防止细菌、真菌和病毒等病菌生长的材料。这些纺织品是透过将银离子、铜和锌等各种抗菌剂嵌入纤维和织物的涂层中而开发的。抗菌医用纺织品主要用于伤口敷料、手术单和个人防护装备 (PPE)。在此类应用中,抗菌品质在预防感染、降低交叉污染风险和改善整体医疗卫生方面发挥重要作用。这些材料也用于医院寝具和製服,为病人和医护人员保持清洁和安全的环境。
抗菌医用纺织品前景广阔,研究仍在继续,旨在提高其有效性并扩大其应用。该研究旨在创造即使在反覆洗涤后仍具有持久抗菌性能的纺织品,并提高其与各种医疗设备和治疗的相容性。
人们越来越有兴趣将感测器和药物传输系统等智慧技术融入抗菌纺织品中,以提供更有针对性和响应更快的医疗保健解决方案。随着对感染控制和病人安全的需求增加,由于材料科学的进步和对医疗保健相关感染的认识不断提高,抗菌医用纺织品的市场可能会扩大。
医疗环境中卫生意识的提高预计将刺激抗菌医用纺织品市场。 COVID-19 大流行显着提高了感染控制意识,促使医疗机构更加重视卫生。世界卫生组织 (WHO) 强调采取感染预防措施的必要性,指出仅保持良好的手部卫生即可将医疗保健相关感染减少高达 50%。人们对卫生的日益关注正在推动磨砂膏和床单等抗菌纺织品的采用,以提高安全性并降低感染风险,从而推动市场成长。
医疗保健相关感染 (HAI) 的增加预计将推动抗菌医用纺织品市场的发展。美国疾病管制与预防中心 (CDC) 报告称,大约三分之一的医院患者每天至少经历一次医院感染,这增加了对传染病缓解解决方案的需求。抗菌医用纺织品对于最大限度地减少这些风险和提高医疗保健环境的安全性至关重要,因此对于应对高医院感染率的机构来说越来越受欢迎。
原物料价格上涨预计将限制抗菌医用纺织品市场的成长。这些纤维的生产通常涉及银离子、铜和其他抗菌化合物等先进成分,因此它们往往很昂贵。原料成本上涨也增加了整体製造成本,增加了医疗机构抗菌医用纺织品的成本。这种成本负担可能会限制采用并减缓市场扩张,特别是在预算紧张的地区和设施。原材料价格的波动会为製造商带来不确定性并限制市场扩张。
抗菌医用纺织品的弹性和寿命可能会限制市场扩张。这些纺织品的目的是持久耐用并随着时间的推移保持抗菌性能,但耐用性的提高可能意味着更换频率的降低,从而导致需求减少。投资于高品质、持久抗菌纺织品的医疗机构可能会发现新产品采购需求下降,从而减缓市场成长。与耐用纤维相关的高昂初始成本可能会阻止一些买家,特别是那些寻求具有成本效益的短期解决方案的买家,并限制市场进步。
The rising healthcare burden, as well as the growing emphasis on infection prevention and control, are driving up demand for antimicrobial medical textiles. As healthcare expenses rise, there is an increasing demand for effective and cost-effective solutions to reduce healthcare-associated infections (HAIs). Antimicrobial textiles are a viable strategy for preventing the spread of hazardous infections, improving patient outcomes, and lowering healthcare costs. The market size surpass USD 15.51 Billion valued in 2024 to reach a valuation of aroundUSD 26.07 Billion by 2031.
The growing frequency of antibiotic resistance poses a substantial threat to public health. Antimicrobial textiles can help address antibiotic resistance by providing an alternate method of infection control that does not use antibiotics. By adding antimicrobial qualities to medical textiles, healthcare institutions can provide a more sanitary atmosphere and reduce dependency on antibiotics, lowering the incidence of antibiotic-resistant illnesses. The rising demand for cost-effective and efficient antimicrobial medical textiles is enabling the market grow at aCAGR of 7.40% from 2024 to 2031.
Antimicrobial Medical Textiles Market: Definition/ Overview
Antimicrobial medical textiles are materials that prevent the growth of germs like bacteria, fungi, and viruses. These textiles are developed with various antimicrobial agents, such as silver ions, copper, or zinc, that are embedded into the fibers or coatings of the fabric. Antimicrobial medical textiles are primarily used for wound dressings, surgical drapes, and personal protective equipment (PPE). In these uses, antimicrobial qualities serve to prevent infections, reduce the risk of cross-contamination, and improve overall medical hygiene. These materials are also utilized in hospital bedding and uniforms to keep the atmosphere clean and safe for both patients and healthcare workers.
Antimicrobial medical textiles appear promising, with continuous research aiming at enhancing their effectiveness and broadening their applications. Research is aimed at creating textiles with longer-lasting antimicrobial characteristics, even after repeated washes, as well as improving their compatibility with various medical equipment and therapies.
There is a rising interest in incorporating smart technologies like sensors and medicine delivery systems into antimicrobial textiles to give more focused and responsive healthcare solutions. As the demand for infection control and patient safety grows, the market for antimicrobial medical textiles is likely to expand, owing to advances in materials science and growing awareness of healthcare-related infections.
Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.
The increasing awareness of hygiene in medical settings is projected to fuel the antimicrobial medical textiles market. The COVID-19 pandemic has considerably increased awareness of infection management, resulting in a greater emphasis on hygiene in healthcare settings. The World Health Organization (WHO) states that adequate hand cleanliness alone can reduce healthcare-associated infections by up to 50%, emphasizing the necessity of infection prevention measures. This increased emphasis on hygiene is hastening the adoption of antimicrobial fabrics, such as scrubs and bed linens, to improve safety and lower the risk of infection, hence driving market growth.
The rising number of healthcare-associated infections (HAIs) is predicted to fuel the antimicrobial medical textiles market. With the Centers for Disease Control and Prevention (CDC) reporting that approximately one in every 31 hospital patients experiences at least one HAI on any given day, the demand for infection-mitigation solutions is increasing. Antimicrobial medical textiles are essential in minimizing these risks and improving safety in healthcare environments, making them increasingly desirable as facilities work to tackle the high occurrence of HAIs.
The high price of raw materials is projected to restrict the growth of the antimicrobial medical textiles market. The manufacture of these fabrics generally involves advanced ingredients like silver ions, copper, and other antibacterial compounds, which can be expensive. As raw material costs grow, so do overall production costs, increasing the cost of antimicrobial medical textiles for healthcare facilities. This cost burden may limit adoption, particularly in regions or institutions with tight budgets, delaying market expansion. Fluctuations in raw material prices can cause uncertainty for manufacturers, limiting the market's expansion.
The resilience and lifespan of antimicrobial medical textiles can limit market expansion. While these textiles are intended to be long-lasting and retain antibacterial characteristics over time, their increased durability may reduce the frequency of replacements, resulting in lesser demand. Healthcare facilities that invest in high-quality, long-lasting antimicrobial textiles may reduce the demand for new product purchases, thereby slowing market growth. The initial greater cost associated with durable fabrics may deter some purchasers, particularly those seeking more cost-effective, short-term solutions, limiting the market's progress.
Cotton, a natural material, has long held the lead in the antimicrobial medical textiles market. Biocompatibility is expected to propel the cotton section of the antimicrobial medical textiles market. Cotton is a natural, hypoallergenic, and highly biocompatible material, making it ideal for use in medical settings where skin sensitivity and comfort are essential. Cotton's ability to be easily treated with antibacterial agents while maintaining its softness and breathability adds to its attractiveness. As healthcare professionals prioritize materials that are both effective and soft on the skin, demand for cotton-based antimicrobial textiles is likely to rise, boosting the market for this sector.
The risk of skin irritation and allergies may boost the expansion of the cotton segment in the antimicrobial medical textile market. Cotton is known for its natural softness, breathability, and hypoallergenic characteristics, which make it easier to cause skin irritation or allergic reactions than synthetic fibers. As healthcare professionals and patients become more aware of the necessity of skin-friendly materials, particularly in settings where extended contact with textiles is common, demand for cotton-based antimicrobial textiles is likely to rise. This emphasis on reducing skin irritation and allergies benefits the cotton portion of the market.
Hospitals and clinics dominate the antimicrobial medical textiles market. The danger of healthcare-associated infections (HAIs) is expected to boost the hospital and clinic segment of the antimicrobial medical textiles market. HAIs are a substantial hazard in healthcare settings, causing longer hospital stays, higher medical expenses, and increased patient morbidity. To tackle these hazards, hospitals and clinics are increasingly using antimicrobial materials including bedding, uniforms, and surgical drapes to help prevent the spread of infections. As the emphasis on infection control grows, demand for these textiles in hospitals and clinics is likely to increase, boosting growth in this market segment.
The growing need to comply with stringent infection control requirements is expected to promote the use of antimicrobial fabrics in the hospital and clinic segment of the antimicrobial medical textiles market. Regulatory entities and healthcare organizations are implementing strict requirements to prevent healthcare-associated infections (HAIs) and increase patient safety. To achieve these standards, hospitals and clinics are turning to antimicrobial textiles, such as gowns, bed linens, and curtains, which are an efficient way to reduce infection risks. This regulatory pressure encourages healthcare facilities to invest in antimicrobial fabrics, fueling growth in this market segment.
North America leads the antimicrobial medical textiles market. North America's well-developed healthcare infrastructure is projected to drive the regional antimicrobial medical textiles market. As of 2022, the United States had 6,093 hospitals with 919,649 staffed beds, and the Centers for Medicare & Medicaid Services expects national health spending to increase at a 5.4% annual rate, reaching approximately USD 7.2 Trillion by 2031. A projected 13% increase in healthcare occupations, adding about 2 million new employments by 2031, will boost demand for antimicrobial fabrics.
High investment in medical technologies is propelling the antimicrobial medical textiles market in North America. The US medical technology market, valued at USD 176 Billion in 2022 and projected to increase at a 5% compound annual growth rate through 2025, has a strong financial commitment to innovation. Investment in digital health companies, which raised USD 29.1 Billion in 2021, and the National Institutes of Health's $45.1 billion research budget for fiscal year 2023 are speeding up the development of advanced medical technology, such as antimicrobial fabrics. This investment is vital in addressing the critical issue of healthcare-associated infections, which affect one out of every 31 hospital patients daily, according to the CDC. The convergence of significant financial backing and the requirement for enhanced infection control solutions is driving the expansion of the antimicrobial medical textiles market in North America.
The Asia-Pacific region's antimicrobial medical textiles market is expanding rapidly. Rapid economic expansion in Asia-Pacific is propelling the antimicrobial medical textiles market. The regional economy is expected to grow by 4.8% in 2024 and is anticipated to reach 5.2%; thereby, resulting in considerable increase in healthcare spending. According to the World Health Organization (WHO), health spending in the Western Pacific Region has increased at an average yearly rate of 6.5%, significantly higher than the global average of 3.9%. China's healthcare spending is estimated to exceed USD 2.3 Trillion by 2030. This economic boom, combined with the high incidence of healthcare-associated infections (HAIs), which in some locations can reach 15.5 illnesses per 100 patients, is driving demand for sophisticated antimicrobial fabrics.
Cost-effective manufacturing is propelling the Asia-Pacific region's expansion in the antimicrobial medical textiles market. In 2022, Asia-Pacific accounted for 51.5% of global manufacturing value-added, with China accounting for 28.7%, and manufacturing labor costs in the region are much lower than in Western countries, with Vietnam paying $2.99 per hour vs $29.81 in the United States. This cost advantage attracts worldwide corporations, resulting in increasing textile manufacturing and exports, including innovative antimicrobial materials. The market for antimicrobial textiles is rapidly expanding, with projected spending on healthcare-acquired infection control reaching USD 3.2 Billion by 2025, owing to high rates of healthcare-associated infections (HAIs) in Southeast Asia, where prevalence can reach 15.5 per 100 patients.
The antimicrobial medical textiles market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.
The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the antimicrobial medical textiles market include: